The JASMINE study met the primary endpoint and key secondary and exploratory endpoints, including those indicating the potential of nipocalimab for steroid sparing SLE is one of the most prevalent… Read More
The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indications Allschwil, CH – Idorsia Ltd announces the initiation of a Phase 2… Read More
Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 status High GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impact… Read More
MAVIRET is the first and only oral eight-week pan-genotypic treatment option approved for people with acute or chronic hepatitis C virus (HCV) in Canada MAVIRET received approval through Health Canada’s… Read More
Toronto, ON – LifeLabs, Canada’s leading provider of laboratory diagnostics, has been voted by Canadians as the Most Trusted Brand in Health Diagnostic Services for the fourth consecutive year, earning the prestigious 2026 BrandSpark Most… Read More
